Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors

Clinical trial NCT07444814 · RECRUITING

Trial details

NCT number: NCT07444814
Sponsor: Whitehawk Therapeutics, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Endometrial Cancer Ovarian Cancer Ovarian Cancer Metastatic Ovarian Cancer Metastatic Recurrent Non-squamous EGFR Wt NSCLC Platinum Resistant Ovarian Cancer PROC

Start date: 2025-12-19
Primary completion: 2028-10-01
Enrollment: 226

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.